1. Home
  2. ARL vs TKNO Comparison

ARL vs TKNO Comparison

Compare ARL & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARL
  • TKNO
  • Stock Information
  • Founded
  • ARL 1999
  • TKNO 1996
  • Country
  • ARL United States
  • TKNO United States
  • Employees
  • ARL N/A
  • TKNO N/A
  • Industry
  • ARL Building operators
  • TKNO Medicinal Chemicals and Botanical Products
  • Sector
  • ARL Real Estate
  • TKNO Health Care
  • Exchange
  • ARL Nasdaq
  • TKNO Nasdaq
  • Market Cap
  • ARL 245.7M
  • TKNO 236.6M
  • IPO Year
  • ARL N/A
  • TKNO 2021
  • Fundamental
  • Price
  • ARL $15.39
  • TKNO $4.62
  • Analyst Decision
  • ARL
  • TKNO
  • Analyst Count
  • ARL 0
  • TKNO 0
  • Target Price
  • ARL N/A
  • TKNO N/A
  • AVG Volume (30 Days)
  • ARL 1.9K
  • TKNO 201.0K
  • Earning Date
  • ARL 11-06-2025
  • TKNO 11-06-2025
  • Dividend Yield
  • ARL N/A
  • TKNO N/A
  • EPS Growth
  • ARL N/A
  • TKNO N/A
  • EPS
  • ARL 0.36
  • TKNO N/A
  • Revenue
  • ARL $49,060,000.00
  • TKNO $39,801,000.00
  • Revenue This Year
  • ARL N/A
  • TKNO $9.52
  • Revenue Next Year
  • ARL N/A
  • TKNO $15.20
  • P/E Ratio
  • ARL $43.16
  • TKNO N/A
  • Revenue Growth
  • ARL N/A
  • TKNO 9.50
  • 52 Week Low
  • ARL $9.43
  • TKNO $3.94
  • 52 Week High
  • ARL $18.00
  • TKNO $10.37
  • Technical
  • Relative Strength Index (RSI)
  • ARL 47.12
  • TKNO 46.82
  • Support Level
  • ARL $14.95
  • TKNO $4.25
  • Resistance Level
  • ARL $15.52
  • TKNO $4.79
  • Average True Range (ATR)
  • ARL 0.33
  • TKNO 0.36
  • MACD
  • ARL -0.10
  • TKNO 0.01
  • Stochastic Oscillator
  • ARL 21.42
  • TKNO 55.56

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: